Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis

Hematology

Volumn 13, Issue 5, 2008, Pages 282-285

  Phillips, Joseph ^a   Staszewski, Harry ^b,c   Garrison, Michael ^b,c  

^a Ochsner Cancer Institute   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Hemophagocytosis; Histoplasma capsulatum; HLH

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN; ASPARTATE AMINOTRANSFERASE; ATOVAQUONE; CEFEPIME; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; DOXYCYCLINE; ETOPOSIDE; FERRITIN; HAPTOGLOBIN; INTERLEUKIN 2 RECEPTOR ALPHA; ITRACONAZOLE; LACTATE DEHYDROGENASE; MOXIFLOXACIN; PREDNISONE; TRIACYLGLYCEROL;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW EXAMINATION; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPNEA; HEMODIALYSIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; KIDNEY FAILURE; MALE; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; SARCOIDOSIS; SIDE EFFECT; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; UPPER RESPIRATORY TRACT INFECTION;

AGED; HISTOPLASMOSIS; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; SARCOIDOSIS; STEROIDS;

EID: 55849135773     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453308X316013     Document Type: Article

References (19)

1. Scott R, Robb-Smith A. Histiocyte medullary reticulosis. Lancet 1939; 2: 194-198.
2. Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child 1952; 27: 519-525.
3. Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005: 82-88.
4. Henter J-I, Söder O, Ö st Å, Elinder G. Incidence and clinical features of familial hemophagocytic lymphohistiocytosis in Sweden. Acta Paediatr Scand 1991; 80: 428-435.
5. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221-230.
6. Henter JI, Elinder G, Ö st Å. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29-33.
7. Stephan JL, Zeller J, Hubert P et al. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993; 11: 451-456.
8. Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of hemophagocytic lymphohistiocytosis. Br J Haematol 2001; 114: 761-769.
9. Janka G, Elinder G, Imashuku S, Schneider M et al. Infection and malignancy associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 435-444.
10. Fadeel B, Orrenius S, Henter J-I. Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients. Br J Haematol 1999; 106: 406-415.
11. Fadeel B, Orrenius S, Henter J-I. Familial hemophagocytic lymphohistiocytosis: too little cell death may seriously damage your health. Leuk Lymphoma 2001; 42: 13-20.
12. Prahalad S, Bove KE, Dickens D et al. Etanervept in the treatment of macrophage activation syndrome. J Rheumatol 2001; 28: 2120-2124.
13. Imashuku S, Hibi S, Kuriyama K et al. Management of severe neutropenia with cyclosporine during initial treatment of epsteinbarr virus-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2000; 36: 393-346.
14. François B, Trimoreau F, Vignon P et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 1997; 103: 114-120.
15. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005; 135: 299-314.
16. Imashuku S, Hibi S, Sako M et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 1995; 86: 4706-4707.
17. Henter JI, Chow CB, Leung CW, Lau YL. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet 2006; 367: 870-873.
18. To KF, Chan PK, Chan KF et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001; 63: 242-246.
19. Lee DCW, Cheung CY, Law AHY et al. p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J Virol 2005; 79: 10147-10151.